We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.05%
AUM
$271M
AUM Growth
+$14.8M
Cap. Flow
-$109K
Cap. Flow %
-0.04%
Top 10 Hldgs %
32.4%
Holding
170
New
10
Increased
48
Reduced
63
Closed
6

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$3.13M
2
AMGN icon
Amgen
AMGN
+$1.13M
3
DLR icon
Digital Realty Trust
DLR
+$366K
4
TRIB
Trinity Biotech
TRIB
+$362K
5
WRK
WestRock Company
WRK
+$332K

Sector Composition

Rank Sector Weight
1 Healthcare 23.01%
2 Technology 21.3%
3 Industrials 15.13%
4 Consumer Staples 9.12%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$209B
$11.3M 4.16%
64,934
+6,376
+11% +$1.13M
MSFT icon
2
Microsoft
MSFT
$3.44T
$11M 4.06%
128,715
-1,968
-2% -$161K
MMM icon
3
3M
MMM
$91.3B
$10.6M 3.92%
54,086
-8,333
-13% -$1.6M
JNJ icon
4
Johnson & Johnson
JNJ
$621B
$9.15M 3.37%
65,496
+268
+0.4% +$37.3K
TROW icon
5
T. Rowe Price
TROW
$24.1B
$8.74M 3.22%
83,283
-3,111
-4% -$303K
BOOM icon
6
DMC Global
BOOM
$136M
$8.6M 3.17%
343,184
+3,650
+1% +$74.9K
XOM icon
7
ExxonMobil
XOM
$645B
$7.76M 2.86%
92,822
-2,335
-2% -$193K
AAPL icon
8
Apple
AAPL
$4.49T
$7.68M 2.83%
181,528
+644
+0.4% +$26.9K
RMD icon
9
ResMed
RMD
$30.7B
$6.57M 2.42%
77,588
-860
-1% -$71K
OFLX icon
10
Omega Flex
OFLX
$298M
$6.49M 2.39%
90,877
-778
-0.8% -$51.6K
FISV
11
Fiserv Inc
FISV
$28.7B
$5.9M 2.17%
89,944
-2,774
-3% -$179K
ACN icon
12
Accenture
ACN
$102B
$5.68M 2.09%
37,102
+17
+0% +$2.46K
PEP icon
13
PepsiCo
PEP
$191B
$5.6M 2.06%
46,726
-164
-0.3% -$18.7K
PFE icon
14
Pfizer
PFE
$143B
$5.58M 2.06%
162,336
+495
+0.3% +$16.9K
CSCO icon
15
Cisco
CSCO
$459B
$5.46M 2.01%
142,688
-584
-0.4% -$20.9K
INTC icon
16
Intel
INTC
$463B
$5.45M 2.01%
118,106
-143
-0.1% -$6.24K
PG icon
17
Procter & Gamble
PG
$337B
$5.27M 1.94%
57,365
-172
-0.3% -$15.5K
WY icon
18
Weyerhaeuser
WY
$17.9B
$5.25M 1.93%
148,822
-3,988
-3% -$141K
UPS icon
19
United Parcel Service
UPS
$88.9B
$5.1M 1.88%
42,800
+300
+0.7% +$35.3K
EV
20
DELISTED
Eaton Vance Corp.
EV
$4.18M 1.54%
74,075
-120
-0.2% -$6.35K
TRIB
21
Trinity Biotech
TRIB
$8.09M
$3.63M 1.34%
4,741
+468
+11% +$362K
LH icon
22
Labcorp
LH
$25.5B
$3.56M 1.31%
25,950
-250
-1% -$33K
WLY icon
23
John Wiley & Sons Class A
WLY
$2.65B
$3.43M 1.26%
52,213
-620
-1% -$35.9K
IBM icon
24
IBM
IBM
$210B
$3.1M 1.14%
21,149
-1,245
-6% -$181K
CTSH icon
25
Cognizant
CTSH
$24.9B
$3.06M 1.13%
43,030
+344
+0.8% +$25.1K

Similar funds

Hunter Associates Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Hunter Associates Investment Management held 170 positions worth $271M, up 5.8% from $257M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Hunter Associates Investment Management's Q4 2017 filing shows 10 new, 48 increased, 63 reduced and 6 closed positions. Its largest new stake was Aptiv: 32,895 shares worth $2.79M. The largest sale was Enterprise Products Partners, an estimated $1.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Hunter Associates Investment Management's largest Q4 2017 buy was Aptiv: 32,895 shares worth $2.79M.
  • Hunter Associates Investment Management added most to Amgen in Q4 2017, an estimated $1.13M increase.
  • Hunter Associates Investment Management's biggest Q4 2017 reduction was Enterprise Products Partners, cutting an estimated $1.9M.
  • Hunter Associates Investment Management fully exited Neos Therapeutics, Inc in Q4 2017, selling an estimated $457K.
  • Hunter Associates Investment Management's ten largest holdings make up 32% of its $271M portfolio in Q4 2017.
  • Hunter Associates Investment Management opened 10 new positions and closed 6 in Q4 2017.
  • Hunter Associates Investment Management's portfolio value rose 5.8% quarter-over-quarter to $271M.

Based on Hunter Associates Investment Management's 13F filing for Q4 2017, filed 15 Feb 2018.